English
Home > Products > CAS NO 2822-41-5

China CAS NO 2822-41-5 Factory

We believe that long expression partnership is often a result of top of the range, value added service, prosperous encounter and personal contact for CAS NO 2822-41-5,2822-41-5,2,3,4-TRIFLUOROPHENOL, Are you still on the lookout for a good quality product that is in accordance together with your very good organization image while expanding your item range? Consider our quality merchandise. Your choice will prove to be intelligent!
CAS NO 2822-41-5, With a wide range, good quality, reasonable prices and stylish designs, our goods are extensively used in beauty and other industries. Our items are widely recognized and trusted by users and can meet continuously changing economic and social needs.

Related Products

Hot Products

  • Cyclophosphamide

    Cyclophosphamide

    Product Name:Cyclophosphamide
    Molecular Formula:C7H15Cl2N2O2P
    Molecular Weight:261.09
    CAS Registry Number:50-18-0
  • Benzyltrimethylammonium hydroxide

    Benzyltrimethylammonium hydroxide

    Product Name:Benzyltrimethylammonium hydroxide
    Molecular Formula:C10H17NO
    Molecular Weight:167.25
    CAS Registry Number:100-85-6
  • Prucalopride

    Prucalopride

    Product Name:Prucalopride
    Molecular Formula:C18H26ClN3O3
    Molecular Weight;367.87
    CAS Registry Number;179474-81-8
  • Gliclazide

    Gliclazide

    Product Name:Gliclazide
    Molecular Formula:C15H21N3O3S
    Molecular Weight;323.41
    CAS Registry Number;21187-98-4
  • 1-Cyclohexylethan-1-one

    1-Cyclohexylethan-1-one

    Product Name:1-Cyclohexylethan-1-one
    Molecular Formula:C8H14O
    Molecular Weight:126.2
    CAS Registry Number:823-76-7
  • 4-Chloro-6-ethyl-5-fluoropyrimidine

    4-Chloro-6-ethyl-5-fluoropyrimidine

    Product Name:4-Chloro-6-ethyl-5-fluoropyrimidine
    Molecular Formula:C6H6ClFN2
    Molecular Weight:160.58
    CAS Registry Number:137234-74-3
  • Related Blog
  • Reviews

  • What is the difference between API and FDF in pharma？

    In the pharmaceutical industry, you might hear the terms “FDF” and “API” frequently used in reference to products. We surely understand this type of jargon, but we certainly can see how the general public would feel overwhelmed looking at those kinds of terminology abbreviations. This article is for explaining the difference between API and FDF. For reference, they mean, respectively, “finished dosage form” and “active pharmaceutical ingredient.”

  • Bosutinib CAS 380843-75-4

    Chemical name:4-(2,4-dichloro-5-methoxyanilino)-6-methoxy-7-[3-(4-methylpiperazin-1-yl)propoxy]quinoline-3-carbonitrile

  • What are pharmaceutical intermediates?

    Pharmaceutical intermediates are fine chemical products in the production process from pharmaceutical chemical raw materials to bulk drugs or drugs. The synthesis of chemical drugs depends on high-quality pharmaceutical intermediates. This chemical, which does not require a drug production license, can be produced in ordinary chemical plants and can be used in the synthesis of drugs as long as it reaches certain grades.

  • Prostate Cancer and Darolutamide

    Prostate cancer results from uncontrollable growth of cancer cells in the prostate gland. The prostate gland is located below the bladder and in front of the rectum, and is only found in males. Almost all prostate cancers (more than 95% of primary prostate cancers) develop from the gland cells and are known as adenocarcinomas (National Cancer Institute, 2017).

  • TOP 8 Linezolid intermediate maker

    Sandoo Pharmaceuticals and Chemicals Co.,Ltd was established in 2009, with a creative and active team, located in Ningbo, China. We have been specialized in exporting and importing pharmaceutical intermediates and chemical products as well as API for more than 10 years, covering more than 10 countries.

  • Tofacitinib More Effective, Alone and in Combinations, than Non-biologic DMARDS

    Tofacitinib (marketed under the brand name Xeljanz) is an oral Janus kinase inhibitor currently approved for the treatment of RA. It was developed in a unique public-private partnership between the National Institutes of Health...

Send Inquiry

Hit enter to search or ESC to close
X
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy
Reject Accept